AdaptHealth Corp. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of AdaptHealth Corp.'s Annual Meeting of Stockholders held on June 18, 2026. The meeting was conducted via live audio webcast. As of the record date (April 24, 2026), there were 120,652,493 shares of Common Stock present or represented by proxy, representing 88.67% of the voting power, which constituted a quorum.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and shareholder voting. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent Form 10-K or 10-Q for financial performance details.
Material Changes and Voting Results
Stockholders voted on three proposals, all of which were approved:
- Election of Directors: All nine nominees were elected to one-year terms. The highest "For" vote was for Kenneth A. Samet (108,390,299 votes), and the lowest was for Ted Lundberg (102,690,918 votes). Broker non-votes totaled 11,875,821 for each director.
- Ratification of Auditors: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes were 119,090,024 For, 1,092,126 Against, and 470,343 Abstain.
- Executive Compensation: The non-binding advisory vote to approve executive compensation passed with 107,129,368 votes For, 965,272 Against, and 682,032 Abstain.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly reports the procedural outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the specific terms of the newly elected directors' service until the 2027 annual meeting.
- Confirm the engagement of KPMG LLP for the fiscal year ending December 31, 2026.
- Note the significant number of broker non-votes (11,875,821) on the director election and executive compensation proposals, indicating shares held in street name where brokers lacked discretionary voting authority.
- Review the definitive proxy statement filed on April 28, 2026, for detailed biographies of directors and executive compensation specifics.